Results from This Site: 21 - 30 of 68 total results for GlaxoSmithKline
  • Key clients include GlaxoSmithKline and Bristol-Myers Squibb. McCann Echo, also based in New Jersey, operates separately, with clients including the GSK/Pfizer ViiV Healthcare business and Novo Nordisk.
  • Gamble and GlaxoSmithKline, both clients for the past 60 years, and Canon for almost 40. Despite the strength of such client relationships, Grey was traditionally better known for careful and methodical
  • followed by GlaxoSmithKline (12.8%) and Unilever (8.1%). In some countries, its share is even higher, as high as 72% in Brazil and over 80% in Mexico. It is also the global market share leader in manual
  • followed by GlaxoSmithKline (12.7%) and Unilever (8.1%). In some countries, its share is even higher. In the UK, for example, Colgate held over 46% value share by mid-2017, according to Nielsen, more
  • sell its portfolio of new HIV drugs in development to GlaxoSmithKline for a total of up to $2.9bn (depending on performance). That arrangement doesn't include drugs already launched. Another fertile
  • to crack the well-established lead of Colgate and GlaxoSmithKline in toothpaste. Crest was tested in the UK in the 2000s, but achieved only limited impact. However, Oral B is the leading toothbrush brand
  • GlaxoSmithKline (UK/US) Profile subscribers click here for full profile GlaxoSmithKline is traditionally regarded as one of Europe's leading pharmaceutical developers but like its peers, it has been
  • later to become part of GlaxoSmithKline) and was the platform for the introduction in 1957 of carbonated orange drink Tango. Meanwhile Whitbread's R Whites had become firmly established as the UK's favourite
  • Bids were received from GlaxoSmithKline, Bayer and Novartis, but the eventual buyer was Reckitt Benckiser, with an offer of £1.9bn. Financials Alliance Boots showed a welcome return to form as a privately
  • second-largest British company in that sector after GlaxoSmithKline. It has no exposure to over-the-counter healthcare, but manages a sizeable portfolio of prescription products, including eight $1bn-

All rights reserved © Mind Advertising Ltd 1998-2019